Literature DB >> 10376165

Comorbidity of headache and depressive disorders.

D D Mitsikostas1, A M Thomas.   

Abstract

The goal of the present study was to investigate the clinical profile of patients with primary headache syndromes who also suffer from mood disorders. Four-hundred-and-seventy headache outpatients (170M, 300F) and 150 age- and sex-matched healthy subjects were screened using a specific questionnaire that included the Hamilton rating scales for anxiety and depression. The average scores of the Hamilton rating scales for anxiety and depression were significantly higher in headache sufferers (17.4 and 14.2, respectively) than in healthy people (6.8 and 5.7, respectively). The frequency of headache attacks, the history of headaches, and gender (women more than men) were correlated with the score of the Hamilton rating scale for both anxiety and depression. Sixteen headache patients (3.4%) achieved the DSM-IV criteria for major depression or dysthymia versus one among headache-free subjects (0.6%; OR 5.2). Patients suffering from drug-overuse and migraine with aura showed the higher odds ratios (35 and 17, respectively). These results suggest that those headache patients with long history and high frequency of headaches, or patients suffering from migraine with aura and drug-overuse might benefit from psychiatric evaluation.

Entities:  

Mesh:

Year:  1999        PMID: 10376165     DOI: 10.1046/j.1468-2982.1999.019004211.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  49 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Higher augmentation index is associated with tension-type headache and migraine in middle-aged/older humans with obesity.

Authors:  Graziela Z Kalil; Ana Recober; Ann Hoang-Tienor; Miriam Bridget Zimmerman; William G Haynes; Gary L Pierce
Journal:  Obesity (Silver Spring)       Date:  2016-02-05       Impact factor: 5.002

3.  Psychiatric comorbidity in different organic vertigo syndromes.

Authors:  Annegret Eckhardt-Henn; Christoph Best; Sandra Bense; Peter Breuer; Gudrun Diener; Regine Tschan; Marianne Dieterich
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

4.  Understanding of headache patterns modification in an emergency department during the economic crisis of Greece.

Authors:  Anastasia Bougea; Nicolaos Spantideas; Evangelos Anagnostou; Efthalia Massou; Sophia Xirou; Thomas Thomaidis; Ioannis Evdokimidis; Evangelia Kararizou
Journal:  Neurol Sci       Date:  2016-04-08       Impact factor: 3.307

5.  A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.

Authors:  Dimitrios Papadopoulos; Dimos Dimitrios Mitsikostas
Journal:  J Neurol       Date:  2011-08-03       Impact factor: 4.849

Review 6.  Psychiatric comorbidity of chronic daily headache: impact, treatment, outcome, and future studies.

Authors:  Shuu-Jiun Wang; Kai-Dih Juang
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 7.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

8.  Psychiatric comorbidity and suicide risk in patients with chronic migraine.

Authors:  Maurizio Pompili; Gianluca Serafini; Daniela Di Cosimo; Giovanni Dominici; Marco Innamorati; David Lester; Alberto Forte; Nicoletta Girardi; Sergio De Filippis; Roberto Tatarelli; Paolo Martelletti
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

9.  Psychiatric comorbidity of headache in a medical relief camp in a rural area.

Authors:  Himanshu Sharma; Savan Shah
Journal:  Indian J Psychiatry       Date:  2006-07       Impact factor: 1.759

10.  Are sleep difficulties associated with migraine attributable to anxiety and depression?

Authors:  Angeliki Vgontzas; Lihong Cui; Kathleen R Merikangas
Journal:  Headache       Date:  2008-07-01       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.